|
|
|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Glaucoma, open- angle |
|
Hypertension, ocular |
| |
|
|
SIDE EFFECTS:
|
|
breast abscess |
|
change in taste |
|
chest pain |
|
confusion or mental depression |
|
congestive heart failure |
|
coughing, wheezing, or troubled breathing, especially in patients with predisposition to bronchoconstriction |
|
cystitis |
|
diarrhea |
|
dizziness or feeling faint |
|
drowsiness |
|
ear pain |
|
epistaxis |
|
gout |
|
hallucinations |
|
headache |
|
heartblock |
|
hypercholesterolemia |
|
hyperlipidemia |
|
hypertension |
|
hypertonia |
|
hypotension |
|
impotence |
|
infection |
|
insomnia |
|
irregular, slow, or pounding heartbeat |
|
nasal congestion |
|
nausea or vomiting |
|
otitis media |
|
paresthesia |
|
pharyngitis |
|
psoriasis |
|
rhinitis or sinusitis |
|
systemic lupus erythematosus |
|
tachycardia |
|
tinnitus |
|
toxic epidermal necrolysis |
|
unusual tiredness or weakness |
|
vascular anomoly |
|
vertigo |
|
Blurred vision, transient |
|
decreased night vision |
|
stinging of eye or other eye irritation, transient upon administration of medication |
|
Browache |
|
constipation |
|
corneal sensitivity |
|
crusting of eyelashes |
|
dermatitis |
|
dryness of eye |
|
dyspepsia |
|
foreign body sensation |
|
increased sensitivity of eye to light |
|
redness, itching, stinging, burning, or watering of eye or other eye irritation |
|
tendinitis |
|
Conjunctival hyperemia |
|
Anisocoria |
|
blepharitis |
|
blepharoconjunctivitis |
|
cataracts |
|
conjunctivitis |
|
corneal punctate keratitis |
|
dermatitis of eyelid |
|
edema |
|
iridocyclitis |
|
keratitis |
|
blepharoptosis |
|
corneal staining |
|
decreased corneal sensitivity |
|
diplopia |
|
eye pain |
|
glossitis |
|
vision disturbances |
|
vitreous disorders |
|
Allergic reaction |
|
alopecia |
|
anxiety or nervousness |
|
arthritis or myalgia |
|
ataxia |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
>> Allergic reactions, severe |
|
>> Bronchitis, nonallergenic |
|
>> Emphysema |
|
>> Pulmonary function impairment, other |
|
Cerebrovascular insufficiency |
|
>> Congestive heart failure |
|
>> Cardiac failure |
|
Heart block |
|
>> Diabetes mellitus, especially labile diabetes |
|
>> Hypoglycemia |
|
>> Hyperthyroidism |
|
Myasthenia gravis |
|
|
ADULT DOSE:
|
|
Ophthalmic antiglaucoma agent-Topical, to the conjunctiva, 1 drop of a 0.25 or 0.5% solution of timolol (base) one or two times a day. |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Ophthalmic antiglaucoma agent-Infants and children up to 10 years of age: Topical, to the conjunctiva, 1 drop of a 0.25% solution of timolol (base) one or two times a day.
Children 10 years of age and older: See Usual adult and adolescent dose.
Note: Nasolacrimal occlusion should be emphasized to patient. |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
|
|
|
|
|
|